Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Anti-CD19-CAR by Kecellitics Biotech for B-Cell Leukemia: Likelihood of Approval
Anti-CD19-CAR is under clinical development by Kecellitics Biotech and currently in Phase I for B-Cell Leukemia. According to GlobalData, Phase...